Preliminary Study on the Effects of Novel Retinoids SX-115 and CHU-012 on NB4 Cell Line
- Author:
Yiyun YAO
1
;
Guanlin SUN
;
Zongru GUO
;
Weili WU
;
Yun WANG
;
Hui SU
Author Information
1. Ruijin Hospital, Shanghai Institute of Hematology, Shanghai Second Medical University, Shanghai 200025, China; The 9th People's Hospital, Shanghai Second Medical University, Shanghai 200000, China; Xinhua Hospital, Shanghai Second Medical University, Shanghai 200092, China; Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China.
- Publication Type:Journal Article
- From:
Journal of Experimental Hematology
2000;8(3):185-188
- CountryChina
- Language:Chinese
-
Abstract:
In this research, the effects of two new retinoids, SX-115 and CHU-012, on promyelocytic leukemia cell line NB4 were studied in vitro. Cell proliferation, cell morphologic characters, cell cycle kinetics, reduction ability of NBT, differentiation antigens, immunofluorescence staining and RT-PCR were adopted as the observational parameters. The results showed that SX-115 and CHU-012 induced differentiation of NB4 cells at concentration of 10(-6) mol/L. Comparing the effects of the two retinoids with all trans-retinoic acid (ATRA) at same concentration, there was no significant difference among the three agents. The mechanism of the 2 new retinoids remains possibly the same as ATRA.
